FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/09/094885 [Registered on: 16/09/2025] Trial Registered Prospectively
Last Modified On: 15/09/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Other 
Public Title of Study   A Study of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan 2drops four times a day In Kaphabhishyanda with special reference To Simple Allergic conjunctivitis. 
Scientific Title of Study   A Randomized Controlled Clinical Study Of Efficacy Of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic conjunctivitis. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Vd SWAPNALI RAMESH PATEKAR 
Designation  Pg Scholar 
Affiliation  Government Ayurvedic College And Hospital Nanded 
Address  shalakyatantra department government ayurved college vazirabad Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  9421639562  
Fax    
Email  swapnalipatekar04@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr N. A .KHAN 
Designation  Professor 
Affiliation  Government Ayurvedic College And Hospital Nanded 
Address  Department Of Shalyakyatantra Government Ayurvedic College And Hospital Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  9325607099  
Fax    
Email  dr.khan_na@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  DrN A KHAN 
Designation  Professor 
Affiliation  Government Ayurvedic College And Hospital Nanded 
Address  Department Of Shalyakyatantra Government Ayurvedic College And Hospital Nanded

Nanded
MAHARASHTRA
431601
India 
Phone  9325607099  
Fax    
Email  dr.khan_na@yahoo.com  
 
Source of Monetary or Material Support  
self sponsored, shalakyatantra department Government ayurved college nanded 431601 Maharashtra India 
 
Primary Sponsor  
Name  vdswapnali ramesh patekar 
Address  shalakyatantra department Government ayurved college and hospital nanded 
Type of Sponsor  Other [self sponsored] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrSWAPNALI RAMESH PATEKAR  Government Ayurvedic College And Hospital Nanded  Department of Shalakytantra government ayurved college vazirabad Nanded
Nanded
MAHARASHTRA 
09421639562

swapnalipatekar04@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:H108||Other conjunctivitis. Ayurveda Condition: ABISHYANDAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: daruharidra kwath with madhu, Reference: ashthang hruday, Route: Ocular, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 2(drops), Frequency: qid, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: triphala shunthi nimb lodrha kwath , Reference: ashtang sanghrah uttartantra 19/61, Route: Ocular, Dosage Form: Bindu/ Drops (Karna/ Nasa/ Netra), Dose: 2(drops), Frequency: qid, Bhaishajya Kal: Adhobhakta, Duration: 14 Days, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  Diagnosed patients with signs and symptoms of Simple Allergic
conjunctivitis /Kaphabhishyanda. - Patient of 10 to 50 years age group of either gender. - Patients willing for Treatment. - Uncomplicated Simple Allergic Con 
 
ExclusionCriteria 
Details  Associated with other forms of allergic conditions like skin rash, allergic bronchitis,
Atopic and systemic allergic problems. - Cases complicated with superadded infections and corneal ulcers. - Patients not willing for treatment. - Other active infectious systemic disorders / Ophthalmic disord 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To study the role of Triphala, Shunthi, Nimba, Lodhra and Atarushaka Kwatha
Aashchyotan in Kaphabhishyanda With Special Reference To Simple Allergic
conjunctivitis.  
14 days 
 
Secondary Outcome  
Outcome  TimePoints 
To reduce symptoms of simple allergic conjunctivitis.
• To establish the efficacy of Triphala, Shunthi, Nimba, Lodhra and Atarushaka
Kwatha Aashchyotan in Kaphabhishyanda.  
14 days 
 
Target Sample Size   Total Sample Size="33"
Sample Size from India="33" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   30/09/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This is a clinical study of efficacy of trihala,shunthi,nimb,lodhra,attarushak kwath aashchyotan in kaphaj abhishandya with special reference to simple allergic conjuctivitis ,kwath in the form of 2 drops qid for 14 days given to trial group while daruharidra kwath with madhu aashchyotan will be given for control group.The primary objective is to study the role of trial group drug to reduce the symptoms of simple allergic conjunctivitis.
 the data will be assessed for decreasing the symptoms like lacrimation,itching ,conjuctival congestion using gradation chart.the study will be conducted at our centre institute.
 
Close